RTX Pulls Back Hard While Shorts and the Street Both Step Back

RTX Corporation has dropped 12% in a month to $195.50, yet short sellers are not piling in — and that gap between the price action and the bearish conviction it might imply is the most interesting thing about the stock this week.

The price slide has been sharper than most of RTX's closest peers. LMT shed less than 1% on the week and NOC actually gained 2.4%, while GE fell 8% and TDG dropped 5%. RTX's 1.7% weekly decline sits in the middle of the peer pack, but the one-month move of 12% is the standout in this cohort. The stock is trading nearly $40 below the analyst consensus target of $234.82, implying meaningful gap-up potential if sentiment shifts — though that figure reflects analyst moves from July and early August, before the recent slide, so the true implied upside is narrower than the headline suggests.

The lending market tells a notably calm story despite the drawdown. Borrow availability is effectively unlimited — the pool of shares available to lend is so deep it registers at the data ceiling, with roughly 792 million shares ready to be borrowed against only 12.3 million currently shorted. Short interest amounts to under 1% of the free float. That level is too low to treat as a primary signal. What is worth noting is the week-on-week direction: short interest rose 14% over the past five days, from around 10.8 million shares to 12.3 million, after collapsing roughly 40% from a mid-August peak near 21 million. The move this week looks like re-entry after a sharp unwind, not a fresh conviction build. Cost to borrow rose 57% week-on-week to 0.42% — still extremely cheap, confirming there is no stress in the lending market and no mechanical squeeze pressure.

Options positioning adds texture rather than alarm. The put/call ratio at 0.83 is fractionally below its 20-day average of 0.83, putting it essentially at neutral — a z-score near zero. That is a meaningful shift from late August, when the PCR ran above 0.93 and peaked at 1.02 on August 14, the period that coincided with the stock's elevated short interest. As the stock fell through September, options traders grew less defensive, not more. The 52-week low on the PCR is 0.40 and the high is 1.02, so the current reading is squarely in the middle of the historical range — no crowding in either direction.

The Street's reaction to Q2 results in late July was unanimously constructive. Multiple firms raised targets after the print, with Bernstein moving to $232, TD Cowen to $240, and RBC Capital to $250. Jefferies had upgraded the stock to Buy in June. The pattern is broadly bullish consensus with a handful of cautious neutrals — UBS reiterated Neutral even while lifting to $215, and Wells Fargo stayed at Equal-Weight with a $230 target. All of these moves predate the current 12% drawdown, meaning the stock has retraced into the lower end of the target range cluster. The bear case rests on GTF engine and AOG exposure, reliance on government contracts in an uncertain defense-spending environment, and the question of whether the strong Q2 aerospace aftermarket run-rate is sustainable. The bull case leans on portfolio diversification, Collins Aerospace's structural position in commercial aviation, and execution track record. Factor scores are mixed: dividend quality ranks in the 87th percentile and the DTC and utilization ranks are both at the 74th percentile, but EV/EBIT scores in only the 29th percentile — the valuation is not cheap, with EV/EBITDA at 17.3x and a PE of 25.5x that has contracted modestly over the past month.

Insider activity from July and early August was uniformly in one direction: net selling of approximately $6.9 million over the 90-day window. The Collins Aerospace president exercised and sold in late July, the general counsel did the same in August, and the Senior VP and Treasurer sold twice. None of the trades were under a 10b5-1 plan, though several involved option exercises followed by share sales — a compensation-mechanics sequence rather than a pure discretionary conviction call. There were no open-market purchases during the period. The insider signal reinforces caution, but with the stock now trading roughly $25–30 below the prices at which those sales were executed, its informational weight has diminished.

The next earnings event is scheduled for October 20. The July print produced a 9.2% single-day gain and a 10% five-day move — the largest reaction in the recent history. With the stock down 12% from post-earnings levels and the analyst consensus still anchored well above the current price, the October release becomes the clearest near-term reference point for whether the re-rating in September reflects a genuine fundamental shift or simply a rotation out of a crowded winner.